Crinetics Pharmaceuticals: Q2 Earnings Insights

Crinetics Pharmaceuticals CRNX reported its Q2 earnings results on Friday, August 12, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Crinetics Pharmaceuticals missed estimated earnings by 20.9%, reporting an EPS of $-0.81 versus an estimate of $-0.67.

Revenue was up $439 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.15 which was followed by a 5.87% increase in the share price the next day.

To track all earnings releases for Crinetics Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.